Pseudotumor cerebri

Neurosurgery Clinics of North America

Volumn 12, Issue 4, 2001, Pages 775-797

  Kosmorsky, G ^a   Luciano, M G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PSEUDOTUMOR; CEREBROSPINAL FLUID FLOW; HUMAN; OPTIC NERVE; PAPILLEDEMA; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0034810252     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1042-3680(18)30034-2     Document Type: Review

References (204)

1. Pseudobrain abscess
2. Pseudotumor cerebri associated with leuprorelin acetate
3. Permanent visual loss after shunt malfunction
4. Sudden visual loss in pseudotumor cerebri due to central retinal artery occlusion
5. Calcified sub-dural hematomas associated with arrested hydrocephalus: Late sequela of shunt operation in infancy
6. Papilledema and asymptomatic intracranial hypertension in systemic lupus erythematosus
7. Normal pressure pseudotumor cerebri
8. "Benign" intracranial hypertension: A survey of the clinical and radiologic features and long term prognosis
9. Pseudotumor cerebri as a complication of amiodarone therapy
10. Benign intracranial hypertension with spinal and radicular pain: A case report
11. Magnetic resonance imaging in pseudotumor cerebri
12. Optic nerve sheath decompression for pseudotumor cerebri
13. Benign intracranial hypertension
14. Lumboperitoneal shunting for pseudotumor cerebri
15. Mechanisms of cerebrospinal fluid absorption in normal and pathologically altered arachnoid villi
16. Intracranial hypertension and iron deficiency anemia: Report of four cases
17. Pseudotumor cerebri syndrome in systemic lupus erythematosus
18. Macular change in pseudotumor cerebri before and after optic nerve sheath fenestration
19. Low CSF protein concentration in idiopathic pseudotumor cerebri
20. Pseudotumor cerebri and leukoencephalopathy in childhood lupus
21. Intracranial hypertension and sulfamethoxazole
22. Benign intracranial hypertension in Bell's palsy
23. Familial benign intracranial hypertension in depression
24. Intracranial hypertension and papilledema associated with nalidixic acid therapy
25. Problems in the diagnosis and treatment of pseudotumor cerebri
26. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri
27. The rational management of idiopathic intracranial hypertension
28. Enlargement of the blind spot caused by papilledema
29. Results of optic nerve sheath fenestration for pseudotumor cerebri: The lateral orbital approach
30. Visual loss in pseudotumor cerebri: Follow-up of 57 patients from 5-41 years and a profile of 14 patients with permanent severe visual loss
31. Gliomatosis cerebri
32. Pseudotumor cerebri associated with cyclosporine use
33. Hypertensive meningeal hydrops: Syndrome frequently following infection in middle ear or elsewhere in body
34. Occurrence of pseudotumor cerebri during treatment of children with asthma by adrenal steroids
35. Pseudotumor cerebri and hyperthyroidism
36. Pseudotumor cerebri in men
37. Pseudotumor cerebri in pregnancy
38. Pseudotumor cerebri in an obese woman with Turner syndrome
39. The incidence of pseudotumor cerebri: Population studies in Iowa and Louisiana
40. Pseudotumor cerebri and low vitamin A intake
41. Benign intracranial hypertension associated with hypervitaminosis A
42. Benign forms of intracranial hypertension - "Toxic" and "otitic hydrocephalus"
43. Is benign intracranial hypertension a chronic disease
44. Guillain-Barré syndrome (acute infective polyneuritis) with increased intracranial pressure and papilledema
45. Papilloedema, optic atrophy, and blindness due to emphysema and chronic bronchitis
46. Intracranial hypertension and tetracycline therapy
47. Macular abnormalities in papilledema from pseudotumor cerebri
48. Optic nerve sheath fenestration for pseudotumor cerebri
49. Lead intoxication in children: Diagnosis and treatment
50. Papilloedema and fits in hypoparathyroidism
51. Benign intracranial hypertension: A review of 79 cases in infancy and childhood
52. Ischemic optic neuropathy in chronic papilledema
53. "Normal pressure" pseudotumor cerebri
54. Pseudotumor cerebri appearing with unilateral papilledema after trabeculectomy
55. Benign intracranial hypertension. I. Mastoiditis and lateral sinus obstruction
56. Benign intracranial hypertension. III. Pregnancy
57. Increased cerebral blood flow in idiopathic pseudotumour cerebri
58. Long-term intracranial pressure recording in the management of pseudotumor cerebri
59. Treatment of visual loss in pseudotumor cerebri associated with uremia
60. Pseudotumor cerebri following beta-human chorionic gonadotropin hormone treatment for undescended testicles
61. Trochlear nerve palsy as a false localizing sign
62. Neuroimaging of the optic nerve after fenestration for management of pseudotumor cerebri
63. Pseudotumor cerebri and facial pain
64. Optic disc edema in raised intracranial pressure. VI. Associated visual disturbances and their pathogenesis
65. Pathogenesis of oedema of the optic disc (papilloedema)
66. Pathogenesis of oedema of the optic disc
67. Fundus lesions in malignant hypertension. IV. Focal intra-retinal periarteriolar transudates
68. Hydrocephalus and obstruction of the superior vena cava in infancy: Clinical study of the relationship between cerebrospinal fluid pressure and venous pressure
69. Familial benign intracranial hypertension
70. Histiocytosis X with benign intracranial hypertension
71. Computed tomography ventricular size has no predictive value in diagnosing pseudotumor cerebri
72. Pseudotumor cerebri syndrome associated with Lyme disease
73. Diverse clinical applications of percutaneous lumboperitoneal shunts
74. Subretinal neovascularization and papilledema associated with pseudotumor cerebri
75. Insecticide/herbicide exposure, aplastic anemia and pseudotumor cerebri
76. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri)
77. Benign intracranial hypertension. I. Diagnosis and prognosis
78. The definition of a reduced CSF absorption syndrome: A reappraisal of benign intracranial hypertension and related syndromes
79. Reduced CSF absorption syndrome. Reappraisal of benign intracranial hypertension and related conditions
80. Benign intracranial hypertension: Aspects of diagnosis and treatment
81. Benign intracranial hypertension. II. CSF pressure and circulation
82. Cerebrospinal fluid protein and opening pressure in idiopathic intracranial hypertension (pseudotumor cerebri)
83. Pseudotumor cerebri: Risk for cognitive impairment?
84. Elevated intracranial venous pressure as a universal mechanism of pseudotumor cerebri of varying etiologies
85. Optic nerve head drusen and pseudotumor cerebri
86. Pseudotumor cerebri
87. Optic nerve decompression in benign intracranial hypertension
88. Fundus lesions in malignant hypertension. II. A pathologic study of experimental hypertensive optic neuropathy
89. Idiopathic intracranial hypertension. Relationship to depression, anxiety, and quality of life
90. Benign intracranial hypertension in an adult after tetracycline therapy
91. Indomethacin causing pseudotumor cerebri in Bartter's syndrome
92. Pseudotumor cerebri from cranial venous obstruction
93. Visual loss in pseudotumor cerebri from branch retinal artery occlusion
94. Ketoprofen causing pseudotumor cerebri in Bartter's syndrome N
95. Unilateral and highly asymmetric papilledema in pseudotumor cerebri
96. Permanent visual impairment in childhood pseudotumor cerebri
97. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease
98. Severe sudden visual loss caused by pseudotumor cerebri and lumboperitoneal shunt failure
99. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri
100. Papilledema following therapeutic dosages of lithium carbonate
101. Benign intracranial hypertension due to A-hypervitaminosis in adults and adolescents
102. Papilledema caused by iron-deficiency anemia
103. Long-term follow-up on patients with diagnosis of pseudotumor cerebri
104. Papilledema in chronic respiratory acidosis
105. Cerebrospinal fluid circulatory dynamics in pseudotumor cerebri and response to steroid therapy
106. Intraspinal epidermoids
107. Occlusion of the cerebral dural sinuses
108. Ocular manifestations of Reye syndrome
109. Increased cerebral blood volume in benign intracranial hypertension
110. Management of visual loss after optic nerve sheath decompression in patients with pseudotumor cerebri
111. Asymmetric papilledema and visual loss in pseudotumor cerebri
112. Transient oculomotor paralysis in pseudotumor cerebri
113. The effect of acetazolamide and furosemide on CSF production and choroid plexus carbonic anhydrase activity
114. Skew deviation in pseudotumor cerebri
115. The neurologic syndrome due to marked hypercapnia, with papilledema
116. Bilateral visual loss and simultagnosia after lumboperitoneal shunt for pseudotumor cerebri
117. Pseudotumor syndrome associated with cerebral venous sinus occlusion and antiphospholipid antibodies
118. Vitamin A intoxication as a cause of pseudotumor cerebri
119. Macular changes resulting from papilloedema
120. Pseudotumor cerebri associated with pernicious anemia
121. Bilateral optic neuropathy associated with amiodarone therapy
122. Effect of cardiac glycosides on human CSF production
123. Glycerol and hyperosmolar non-ketotic coma
124. CSF shunt infection in pediatrics: A seven-year experience
125. Factors affecting visual loss in benign intracranial hypertension
126. Papilledema and hypoparathyroidism simulating brain tumor
127. Association of xerophthalmia, flecked retina, and pseudotumor cerebri caused by hypovitaminosis A [brief report]
128. Dural sinus thrombosis: A mechanism for pseudotumor cerebri in systemic lupus erythematosus
129. Gaze-evoked amaurosis in pseudotumor cerebri
130. Evaluation of optic nerve sheath fenestration in pseudotumor cerebri using automated perimetry
131. Bilateral optic disk edema caused by sarcoidosis mimicking pseudotumor cerebri [brief report]
132. Operative complications of opticnervesheath decompression
133. Pseudotumor cerebri and hypothyroidism
134. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber layer loss and visual field defect in glaucoma, ischemic neuropathy, papilledema and toxic neuropathy
135. Eiueber meningitis serosa and verwandte zustande
136. Cerebral hemodynamics and metabolism in pseudotumor cerebri
137. Pseudotumor cerebri
138. Pseudotumor cerebri in children receiving recombinant human growth hormone
139. Cerebrospinal fluid diversion procedures in pseudotumor cerebri
140. A clinical analysis of pseudopapilledema. I. Population, laterality, acuity, refractile error, ophthalmoscopic characteristics, and coincident disease
141. Pseudotumor cerebri: Report of familial occurrences
142. The minor symptoms of increased intracranial pressure: 101 Patients with benign intracranial hypertension
143. Pseadotumor cerebri: Clinical profile and visual outcome in 63 patients
144. Transient visual obscurations with elevated optic discs
145. Brain swelling of unknown cause
146. Intracranial hypertension of unknown cause. Cerebral edema
147. Cerebrospinal fluid absorption in primary hypoparathyroidism
148. Pseudotumor cerebri and insecticide intoxication
149. Benign intracranial hypertension associated with delayed penicillin reaction
150. Normal pressure hydrocephalus - High pressure normocephalus
151. Papilledema associated with blood loss anemia
152. Liver lover's headache: Pseudotumor cerebri and vitamin A intoxication
153. Percutaneous lumboperitoneal shunt: Review of 130 cases
154. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri
155. Familial pseudotumor cerebri in the empty sella syndrome
156. Benign intracranial hypertension associated with nitrofurantoin therapy
157. Experience with 1201 cerebrospinal fluid shunt procedures
158. An unusual presentation of pseudotumor cerebri
159. Ocular changes in pulmonary insufficiency
160. Pseudotumor cerebri caused by a synthetic vitamin A preparation
161. Fourth cranial nerve palsy in pediatric patients with pseudotumor cerebri
162. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri
163. Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompression
164. Prognostic significance of papilledema in course of respiratory insufficiency
165. Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity
166. Gastric surgery for pseudotumor cerebri associated with severe obesity
167. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri
168. Fatal tonsillar herniation in pseudotumor cerebri
169. Otitic hydrocephalus
170. Pupillary signs in the diagnosis of optic nerve disease
171. Increased cerebrospinal fluid pressure following unilateral radical neck dissection
172. Treatment of pseudotumor cerebri with Diamox (acetazolamide)
173. Familial benign intracranial hypertension
174. Sudden monocular visual loss in pseudotumor cerebri
175. Optic disc edema in raised intracranial pressure. III. A pathologic study of experimental papilledema
176. Optic disc edema in raised intracranial pressure. IV. Axoplasmic transport in experimental papilledema
177. Triamcinolone and intracranial hypertension: A side effect
178. Pseudotumor cerebri treated
179. Pseudotumor cerebri associated with initiation o flevothyroxine therapy for juvenile hypothyroidism
180. Successful allogeneic bone marrow transplantation in a patient with ATRA-induced pseudotumor cerebri
181. Cerebral arteriovenous malformation with intracranial hypertension
182. Electrophysiology versus psychophysics in the detection of visual loss in pseudotumor cerebri
183. Steroid-induced benign intracranial hypertension
184. Pseudotumor cerebri associated with prolonged corticosteroid therapy
185. Idiopathic intracranial hypertension
186. Treatment of pseudotumor cerebri
187. Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri)
188. Symptoms and disease associations in pseudotumor cerebri: A case control study
189. Idiopathic intracranial hypertension. Lack of histologic evidence for cerebral edema
190. Papilledema associated with increased intracranial pressure in Addison's disease
191. Oral contraceptives and neuro-ophthalmologic interest
192. Tetracycline and benign intracranial hypertension: Report of 5 cases
193. Intracranial serous effusions of inflammatory origin: Meningitis or ependymitis serosa-meningism - With a note on "pseudotumors" of the brain
194. Benign intracranial hypertension
195. Principles of physiology of the cerebrospinal fluid in relation to hydrocephalus, including normal pressure hydrocephalus
196. Pituitary-adrenal function after topical steroids
197. Site and mechanism of vascular stenosis under increased intracranial pressure - Intracranial venous pressure mechanism
198. Severe bilateral papilledema of indeterminate etiology with report of 12 cases
199. Macular subretinal neovascular membrane associated with pseudotumor cerebri